Pew’s Comments on Medical Device User Fee Program Reauthorization

Pew’s Comments on Medical Device User Fee Program Reauthorization

On Aug. 12, 2015, The Pew Charitable Trusts submitted comments to the Food and Drug Administration on the reauthorization of the Medical Device User Fee Amendments for fiscal years 2018 through 2022.

The comments outlined opportunities for the agency to strengthen its postmarket surveillance infrastructure, including the establishment of a national system for medical device evaluation, pilot programs to encourage the documentation and transmission of data related to unique device identifiers, and timely completion of post-approval studies.

Read Pew’s full comments.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up